knowledge -WSS

knowledge

author：comprehensive 2025-09-30 11:06:57 - browse：264

The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT — Eric Risberg/AP

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Supreme Court wrestles with OxyContin maker's bankruptcy deal

WSS

CDC's new outbreak response network to include Northeastern

Ukraine and a new approach to mental health in war

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Intarcia’s device

Senate HELP committee spars over health care workforce policies

CDC's new outbreak response network to include Northeastern

hotspot

knowledge

leisure time

As demand for Covid shots wanes, Moderna seeks its next success

What PEPFAR has meant on the ground in Ukraine

Bright Health sells Medicare Advantage business to Molina

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Hepatitis C has a cure — but many Americans still lack access to it

Americans' trust in science, scientist continues decline: Report

Duchenne breakthrough therapy leaves behind pioneering families

What Congress can do to address the rural doctor shortage

Walensky prepares to leave CDC — and Congress — behind

Hearing on Medicare drug price negotiation gets unusually heated

hotspot

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

It's been 20 years since Dolly the sheep. Where's my clone?

Readout LOUD podcast: possible new ALS drug, artificial wombs

Medical student insurance fails on mental health care coverage

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Pharma patents targeted by Biden in move to slash drug prices

hotspot

entertainment

Wikipedia

hotspot